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INTRODUCTION
Fetal programming associated with intrauterine 
growth restriction (IUGR) leads to lifelong defi-
cits in growth and metabolic function (Hales and 
Barker, 2013). IUGR arises when fetuses respond 
to poor in utero conditions by developing adap-
tations that repartition nutrients to critical tissues 
and away from skeletal muscle (Yates et al., 2012, 
2018). This fetal programming is beneficial in utero 
but leads to persistent reductions in muscle mass 
and glucose homeostasis in offspring (DeFronzo 
et  al., 1981). Recent studies by our laboratory in 
sheep and rats demonstrate that maternal inflam-
mation during gestation induces fetal inflamma-
tory adaptations that impair growth and disrupt 
muscle glucose metabolism (Cadaret et  al., 2017, 
2018). IUGR fetal skeletal muscle exhibits indica-
tors of enhanced inflammatory sensitivity, which 
could disrupt glucose uptake and oxidation (Yates 
et al., 2016; Cadaret et al., 2018). Enhanced inflam-
matory responsiveness would help explain growth 
and metabolic deficits observed in IUGR offspring. 
We hypothesize that fetal programming induced by 
maternal inflammation persists in offspring and 
contributes to impaired growth and glucose metab-
olism at 30 d. Therefore, the objective of this study 
was to determine whether sustained maternal in-
flammation induced by bacterial endotoxin at 0.7 
gestation leads to fetal programming that contrib-
utes to deficits in growth and glucose metabolism 
in offspring.
MATERIALS AND METHODS
Animals and Experimental Design
All procedures were approved by the 
Institutional Animal Care and Use Committee 
at the University of Nebraska–Lincoln, which 
is an AAALAC International accredited insti-
tution. Timed-mated Polypay ewes were treated 
(iv) with saline (control, n = 8) or 0.1 µg/kg bod-
yweight (BW) of bacterial lipopolysaccharide 
(n = 6; Escherichia coli O55:B5; MilliporeSigma) 
every third day from d 100 to 115 of gestation to 
produce maternal inflammation-induced IUGR 
(MI-IUGR) lambs. Lambs were weaned at birth, 
fed colostrum, and transitioned to a commercial 
milk replacer (ad libitum). BW and growth met-
rics were measured at birth and 30 d. At 25 ± 2, 
indwelling catheters and a perivascular flow probe 
were surgically placed in hindlimb femoral arteries 
and veins as previously described (Limesand et al., 
2007; Camacho et al., 2017). Glucose-stimulated 
insulin secretion (GSIS) and hyperinsulinemic-eu-
glycemic clamp (HEC) studies were performed 
at 28 ± 2 and 29 ± 2 d, respectively. Lambs were 
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killed at 30  ± 2 d.  Brains were weighed, and pri-
mary hindlimb skeletal muscle was isolated for ex 
vivo metabolic studies.
Glucose-Stimulated Insulin Secretion
A square-wave hyperglycemic clamp was per-
formed as previously described (Yates et al., 2012; 
Camacho et al., 2017). Three baseline samples were 
collected at 5-min intervals prior to an intravenous 
glucose bolus (150  mg/kg BW) and continuous 
variable-rate glucose infusion to produce steady-
state hyperglycemia ~2-fold greater than baseline. 
Thirty minutes after clamping hyperglycemia, three 
additional blood samples were collected at 5-min 
intervals. Blood was centrifuged (14,000 × g, 2 min, 
4 ºC) and plasma insulin concentrations were deter-
mined via ELISA (Ovine Insulin; Alpco). Intra- and 
inter-assay coefficient of variation were less than 
10%. Whole blood was analyzed for glucose con-
centration using an ABL90 FLEX (Radiometer).
Hindlimb Glucose Metabolism
Hindlimb glucose utilization and oxidation 
rates at baseline and during HEC were quantified as 
previously described (Cadaret et al., 2018). Lambs 
were infused with U-[14C]-glucose tracer (18.75 µCi/
ml; PerkinElmer) at 1 ml/h for 40 min. Then, arterial 
and venous blood samples were collected simultan-
eously at 5-min intervals (four total). Lambs were 
then infused with 33% dextrose at a variable rate 
and insulin (Humulin-R; Eli Lilly) at 4 mU/kg/min 
to produce steady-state hyperinsulinemia and eug-
lycemia. After HEC was achieved for 2 h, simultan-
eous venous and arterial samples were again taken 
at 5-min intervals as described earlier. To measure 
glucose oxidation, blood was added to microcentri-
fuge tubes containing 2 M HCl to release CO2. These 
were suspended inside sealed 20-ml scintillation vials 
containing 1 M NaOH to capture CO2. After 24 h 
at 32 ºC, the microcentrifuge tube was removed and 
Ultima Gold scintillation fluid (PerkinElmer) was 
added to each vial. Concentrations of 14CO2 from 
each blood sample were quantified via liquid scin-
tillation using a Beckman Coulter 1900. Hindlimb 
glucose utilization was calculated as the difference 
between arterial and venous glucose concentrations 
normalized to femoral blood flow rate and hindlimb 
weight at necropsy. Hindlimb glucose oxidation 
rates were quantified in triplicate from the difference 
between venous and arterial 14C-specific activities 
normalized to femoral blood flow rate and hindlimb 
weight at necropsy. The amount of glucose oxidized 
was calculated in nanomol using the specific activity 
of the infused radiolabeled glucose.
Ex Vivo Skeletal Muscle Glucose Metabolism
Primary skeletal muscle glucose uptake and 
oxidation rates were quantified as previously de-
scribed (Cadaret et al., 2017). The flexor digitorum 
superficialis muscle of each lamb was dissected lon-
gitudinally into ~800  mg strips before incubation 
in Krebs–Henseleit bicarbonate buffer (KHB) con-
taining (basal), or 5 mU/ml insulin. Glucose uptake 
was measured in triplicate by incubating muscle in 
KHB containing 1  mM [3H]2-deoxyglucose and 
1 mM [14C]-mannitol for 20 min. Glucose oxidation 
was measured in triplicate by incubating muscle in 
KHB containing [14C-U]D-glucose for 2 h, before 
capturing 14CO2 in NaOH for 2 h as previously de-
scribed (Cadaret et al., 2017).
Statistical Analysis
All data were analyzed using the MIXED 
procedure in SAS (SAS Institute, Cary, NC) with 
lamb as the experimental unit. In vivo and ex vivo 
metabolic data were analyzed for effects due to 
experimental group, period (or incubation condi-
tion), and the interaction. Period or condition was 
treated as a repeated variable. For in vivo meta-
bolic studies, samples within each period were 
averaged for each lamb. Similarly, technical rep-
lications were averaged for each lamb in ex vivo 
studies. Morphometric data were analyzed for ef-
fects due to treatment. All data are presented as 
means ± SEM.
RESULTS
Lamb Growth Metrics
At birth, BW tended to be less (P < 0.1) and average 
daily gain (ADG) from birth to d 30 was less (P < 0.05) 
in MI-IUGR lambs than controls (Table 1). At 30 d, 
BW was ~20% less (P  <  0.05) in MI-IUGR lambs 
than controls. Brain weight or BW was ~19% greater 
(P < 0.05) in MI-IUGR lambs compared to controls.
In Vivo Metabolic Studies
Basal and GSIS did not differ between groups 
(Figure 1). Insulin-stimulated hindlimb glucose 
rates did not differ between groups (data not 
shown). However, hindlimb insulin-stimulated 
glucose oxidation was ~70% less (P  <  0.05) in 
MI-IUGR lambs compared to controls (Figure 2).
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Ex Vivo Skeletal Muscle Glucose Metabolism
Basal and insulin-stimulated glucose uptake 
rates in primary skeletal muscle from MI-IUGR 
lambs was less (P < 0.05) than skeletal muscle from 
controls (Figure 3A). Incubation with insulin in-
creased (P < 0.05) glucose uptake in skeletal muscle 
from all lambs. Glucose oxidation rates were less 
(P < 0.05) in MI-IUGR muscle than controls under 
basal and insulin-stimulated conditions (Figure 
3B). Insulin increased (P < 0.05) glucose oxidation 
in skeletal muscle from all lambs.
DISCUSSION
The results of this study demonstrate that sus-
tained maternal inflammation at 0.7 gestation yields 
IUGR and growth deficits that persist after birth. 
Furthermore, fetal programming responses to ma-
ternal inflammation impaired skeletal muscle glu-
cose metabolism, which also persist after birth. In 
addition to exhibiting asymmetrical growth restric-
tion at birth, MI-IUGR lambs grew ~22% slower, 
making them ~20% smaller at 30 d. Greater brain 
or BW in MI-IUGR lambs was consistent with 
asymmetrical growth and brain-sparing, which 
is a hallmark characteristic of IUGR (Limesand 
et al., 2007). Maternal inflammation yielded less se-
vere IUGR with a less pronounced effect on BW at 
birth than the maternal hyperthermic model (Yates 
et  al., 2018). However, our findings indicate that 
MI-IUGR growth deficits persist in offspring. It is 
worth noting that MI-IUGR lambs did not exhibit 
postnatal catch up growth over the first 30 d after 
birth in this study. Nevertheless, our MI-IUGR 
lambs exhibited substantially less glucose oxida-
tion within hindlimb tissues and in isolated hind-
limb skeletal muscle. Although hindlimb tissues in 
MI-IUGR lambs used normal amounts of glucose, 
ex vivo studies indicated that skeletal muscle-spe-
cific glucose uptake was impaired. We did not ob-
serve evidence of β-cell dysfunction in this study, 
which contrasted with the results of our fetal studies 
in this model of IUGR (Cadaret et al., 2018). These 
findings indicate that sustained maternal inflam-
mation at 0.7 gestation has a substantial negative 
effect on fetal programming of glucose metabolism 
that mirrored other IUGR models (Limesand et al., 
2007; Brown et al., 2015). They further show that 
adaptive fetal programming responses to maternal 
inflammation persist in offspring at 30 d and affect 
muscle tissue responsiveness to insulin. Reductions 
in muscle glucose oxidation could be due to the 
developmental shift toward anaerobic glycolysis 
(Brown et al., 2015; Yates et al., 2018), which pro-
duces lactate for nutrient repartitioning via the 
Cori cycle. We hypothesized in previous studies 
that this shift results from programming of skel-
etal muscle inflammatory signaling that occurs as 
a result of maternal inflammation (Cadaret et al., 
2018; Posont et al., 2018). Such alterations appear 
to enhance skeletal muscle sensitivity to inflamma-
tory cytokines, which would help to explain in part 
the growth and metabolic pathologies we observed 
in this study (Posont et al., 2018; Yates et al., 2018). 
Table 1. Growth measurements for MI-IUGR lambs
Variable Control MI-IUGR P value
Birthweight, kg 4.42 ± 0.16 3.61 ± 0.43 0.09
30 d BW, kg 13.88 ± 0.37 11.06 ± 0.92 0.03
ADG, kg/day 0.32 ± 0.01 0.25 ± 0.02 0.03
30 d Brain/BW 5.91 ± 0.15 7.23 ± 0.34 0.02
Values are expressed as means ± SE. ADG = average daily gain.
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Figure 1. Plasma insulin concentrations in MI-IUGR lambs at 30 
d of age under basal and steady-state hyperglycemic conditions as well 
as the difference between periods. Square-wave hyperglycemic clamps 
were performed in controls (n  =  8) and MI-IUGR (n  =  6) lambs. 
*Means differ (P < 0.05) from controls within the period.
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Figure 2. Hindlimb-specific insulin-stimulated glucose oxida-
tion rates in MI-IUGR lambs at 30 d of age. Square-wave hyperin-
sulinemic-euglycemic clamps were performed in controls (n = 8) and 
MI-IUGR (n = 6) lambs. *Means differ (P < 0.05) from controls.
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Inflammatory responsiveness was not measured in 
this study, but our previous studies found that skel-
etal muscle from MI-IUGR rats and sheep respond 
differently than control muscle to the inflammatory 
cytokine tumor necrosis factor α (Cadaret et  al., 
2017, 2018). Furthermore, we previously found 
differences in inflammatory signaling pathways in 
skeletal muscle and myoblasts of IUGR fetal sheep 
that coincided with altered proliferation and differ-
entiation rates of these cells (Posont et al., 2018). 
Further research will determine how the apparent 
enhancement of these inflammatory pathways 
might contribute to the persistent MI-IUGR meta-
bolic phenotype observed in this study.
In conclusion, sustained maternal inflamma-
tion at 0.7 gestation resulted in IUGR, with mod-
erate effects on postnatal growth but substantial 
effects on skeletal muscle glucose metabolism in 
offspring. Poor skeletal muscle metabolic capacity 
and asymmetrical growth restriction are common 
characteristics of IUGR offspring in humans and 
livestock. The results of this study indicated that 
fetal programming responses to maternal inflam-
mation persist after birth and contribute to deficits 
in growth and glucose metabolism via unknown 
mechanisms. These programmed responses may be 
due to previously observed alterations in inflamma-
tory signaling pathways of skeletal muscle, which 
could represent intervention targets to improve 
outcomes in IUGR offspring.
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